COMP <GO>
ASB vs BAC // 10Y YIELD & FRED MACRO BETA
Associated Banc-Corp (NYSE) VS. Bank of America Corporation (NYSE) • 15-METRIC TALLY: ASB 10
— BAC 3
▲ 10Y YIELD & FRED MACRO BETA LEADER: ASB
LAST: $30.30 (-0.75%) • MKT CAP: $5.67B
macro-sensitivity
1.02
LAST: $50.01 (-2.21%) • MKT CAP: $357.61B
macro-sensitivity
0.90
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ASB VS. BAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ASB | BAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.80% | 2.50% | +0.30 | ASB | /roic <GO> |
| EV/EBITDA & P/E Valuation | 26.8x | 30.2x | -3.40 | ASB | /valuation <GO> |
| Free Cash Flow Yield | 9.60% | 2.10% | +7.50 | ASB | /fcf-yield <GO> |
| Operating Margin | 36.50% | 32.90% | +3.60 | ASB | /operating-margins <GO> |
| Net Profit Margin | 29.90% | 27.00% | +2.90 | ASB | /net-margins <GO> |
| Revenue Growth (YoY) | 9.90% | 6.80% | +3.10 | ASB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.75% | 0.00% | +2.75 | ASB | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 0.45 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ASB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.60% | +0.40 | BAC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.3 | 27.7 | +32.66 | ASB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.02 | 0.90 | +0.12 | ASB | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.1x | 10.9x | +0.20 | BAC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.67B | $357.61B | -$351.94B | BAC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ASB REV | BAC REV | ASB GROSS % | BAC GROSS % | ASB FCF | BAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $113.10B | — | 44.0% | $615.7M | $7.52B |
| FY 2024 | $0 | $105.86B | — | 44.0% | $580.2M | -$13.57B |
| FY 2023 | $1.10B | $102.77B | 44.0% | 44.0% | $393.1M | $40.36B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ASB // BETA 1.02
BAC // BETA 0.90